We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

42 hedge funds and large institutions have $2.09M invested in Actinium Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.07% less ownership

Funds ownership: 0.29% → 0.22% (-0.07%)

7% less funds holding

Funds holding: 45 → 42 (-3)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

33% less capital invested

Capital invested by funds: $3.12M → $2.09M (-$1.03M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
42
Holders Change
-3
Holders Change %
-6.67%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
8
Reduced
9
Closed
6
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$196K
2
Renaissance Technologies
Renaissance Technologies
New York
+$46.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$16.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$15.6K
5
Northern Trust
Northern Trust
Illinois
+$10.2K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$628K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$197K
3
ECM
Endurant Capital Management
California
-$147K
4
CAN
Cetera Advisor Networks
California
-$43K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$23.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFM
26
Hartford Financial Management
Connecticut
$3K – – –
OC
27
Oppenheimer & Co
New York
$3K – – –
RJA
28
Raymond James & Associates
Florida
$3K – – –
SFWA
29
Summit Financial Wealth Advisors
Louisiana
$3K – – –
Wells Fargo
30
Wells Fargo
California
$3K +$242 +34 +7%
TSS
31
Two Sigma Securities
New York
$3K +$575 +81 +22%
Morgan Stanley
32
Morgan Stanley
New York
$3K +$739 +104 +25%
WSFS
33
Wilmington Savings Fund Society
Delaware
$2K – – –
IA
34
IFP Advisors
Florida
$1K – – –
Northwestern Mutual Wealth Management
35
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
ECM
36
Endurant Capital Management
California
– -$147K -22,570 Closed
CAN
37
Cetera Advisor Networks
California
– -$43K -4,217 Closed
SFG
38
SNS Financial Group
Minnesota
– -$8K -1,167 Closed
VFA
39
Valeo Financial Advisors
Indiana
– -$7.1K -1,000 -95%
TC
40
Truvestments Capital
Florida
– -$2K -359 Closed
WS
41
Wedbush Securities
California
– -$2K -333 Closed
Bank of America
42
Bank of America
North Carolina
– -$774 -109 -77%
TWA
43
TCI Wealth Advisors
Arizona
– +$476 +67 New
1
2

ATNM Hedge Fund Activity: Q1 2020 in Review

42 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q1 2020, worth a combined $2.09M — down 33% from $3.12M a quarter earlier.

Fund positioning in ATNM was balanced in Q1 2020: 6 funds opened new positions, 6 closed out, 8 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $196K. The largest seller was Sabby Management, cutting an estimated $628K.

  • 42 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q1 2020, down from 45 in Q4 2019.
  • Funds reported $2.09M of Actinium Pharmaceuticals stock for Q1 2020, down 33% quarter-over-quarter.
  • 6 funds opened new Actinium Pharmaceuticals positions in Q1 2020 and 6 closed out, a net change of 0 holders.
  • The largest Actinium Pharmaceuticals buyer in Q1 2020 was BlackRock, an estimated $196K added.
  • The largest Actinium Pharmaceuticals seller in Q1 2020 was Sabby Management, an estimated $628K sold.

Based on aggregated 13F filings for Q1 2020.